Investigating Cost Implications of Incorporating Level III At-Home Testing into a Polysomnography Based Sleep Medicine Program Using Administrative Data

Table 3

Costs of the HM and PSG arms of the program (in Canadian Dollars), overall and stratified by final disposition, AHI, ESS, gender, and BMI. Rx represents the costs for patients that get a prescription, and discontinued represents those patients that left the program before they received a diagnosis, because of either a negative test or a decision to not pursue treatment.

	Total (sd; )	HM (sd; )	SL (sd; )
Overall	$627.4 (272.99, 10022)	$419.2 (269.46, 3642)	$746.2 (191.78, 6380)
Rx	$623.9 (202.47, 5725)	$464.7 (220.94, 1998)	$709.3 (126.21, 3727)
Discontinued
All drops	$632 (345.23, 4297)	$364 (309.84, 1644)	$798 (247.96, 2653)
Drop after test		$147 (27.97, 833)	—
Drop after treatment		$586.8 (309.5, 811)	—
AHI
	$615.6 (247.47, 1689)	$401.4 (327.28, 386)	$679.1 (173.48, 1303)
	$602.2 (273.26, 2506)	$392.2 (256.1, 985)	$738.2 (183.04, 1521)
	$594.9 (272.64, 2041)	$407 (215.44, 987)	$770.9 (190.96, 1054)
30+	$663.2 (293.39, 3127)	$459.6 (290.59, 1223)	$793.9 (208.44, 1904)
ESS
	$653 (271.23, 2506)	$441.6 (308.87, 739)	$741.4 (194.82, 1767)
	$643.2 (262.19, 2412)	$433.7 (251.69, 812)	$749.5 (194.75, 1600)
	$612.9 (275.02, 2929)	$416.9 (264.71, 1192)	$747.3 (187.22, 1737)
15+	$619.5 (275.93, 1624)	$427.6 (260.55, 673)	$755.4 (193.58, 951)
BMI
	$626 (269.56, 872)	$426.4 (288.24, 274)	$717.5 (203.34, 598)
	$608.2 (270.57, 2214)	$417.8 (274.06, 861)	$729.3 (185.16, 1353)
	$626 (267.96, 2536)	$436.1 (262.73, 997)	$749 (187.43, 1539)
	$638.6 (282.72, 1723)	$419.4 (256.62, 642)	$768.7 (207.04, 1081)
40+	$680.4 (268.13, 1845)	$465.4 (291.4, 535)	$768.2 (200.05, 1310)
Gender
Male	$635.7 (272.33, 6487)	$421.3 (270.5, 2282)	$752.1 (190.29, 4205)
Female	$611.7 (273.19, 3520)	$416.3 (268.22, 1355)	$734.1 (193.54, 2165)